Vitamin D supplementation is effective for olanzapine-induced dyslipidemia

Olanzapine is an atypical antipsychotic drug that is clinically applied in patients with schizophrenia. It increases the risk of dyslipidemia, a disturbance of lipid metabolic homeostasis, usually characterized by increased low-density lipoprotein (LDL) cholesterol and triglycerides, and accompanied...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zijian, Nagashima, Takuya, Toda, Chihiro, Kobayashi, Mone, Suzuki, Takahide, Nagayasu, Kazuki, Shirakawa, Hisashi, Asai, Satoshi, Kaneko, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989177/
https://www.ncbi.nlm.nih.gov/pubmed/36895943
http://dx.doi.org/10.3389/fphar.2023.1135516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989177/
https://www.ncbi.nlm.nih.gov/pubmed/36895943
http://dx.doi.org/10.3389/fphar.2023.1135516

Ejemplares similares